Tingting He
Chongqing Key Laboratory Of Medicinal Chemistry And Molecular Pharmacology
Chongqing, 400054, China
Chongqing, 400054, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Recent progress in targeted membrane protein degradation technology based on aptamers for disease treatment.
Journal: Biomaterials science
Published: November 28, 2025
A coenzyme-based "interface-welding" hydrogel coating for titanium implants promotes diabetic osseointegration by regulating mitochondrial dynamics.
Journal: Biomaterials
Published: October 24, 2025
Heteroaptamer recognition mediated strand displacement amplification for efficient electrochemical analysis of beta-2-microglobulin in breast milk.
Journal: Food chemistry
Published: October 23, 2025
Advancements in the study of exosomes in disease diagnosis and treatment.
Journal: International journal of pharmaceutics
Published: September 19, 2025
Dual targeting of lipid metabolic reprogramming and immunosuppressive sentinel lymph nodes potentiates anti-metastatic therapy for triple negative breast cancer.
Journal: Bioactive materials
Published: June 18, 2025
Multieffect Specific Nanovesicles for Homing Resistant Tumors and Overcoming Osimertinib-Acquired Resistance in NSCLC.
Journal: Advanced healthcare materials
Published: October 30, 2024
Glutathione-Responsive and Hydrogen Sulfide Self-Generating Nanocages Based on Self-Weaving Technology To Optimize Cancer Immunotherapy.
Journal: ACS nano
Published: March 28, 2024
Clinical Management in NSCLC Patients With EGFR Mutation After Osimertinib Progression With Unknown Resistance Mechanisms.
Journal: The clinical respiratory journal
Published: March 08, 2024
Efficacy and Safety of Chemotherapy or EGFR-TKIs as First-Line Therapy in NSCLC Patients Harboring Non-Ex 20 Ins Uncommon EGFR Mutations: A Retrospective Study in China.
Journal: Cancer medicine
Published: December 01, 2023
Sialyltransferase ST3GAL4 confers osimertinib resistance and offers strategies to overcome resistance in non-small cell lung cancer.
Journal: Cancer letters
Published: September 03, 2023
Overall signature of acquired KRAS gene changes in advanced non-small cell lung cancer patient with EGFR-TKI resistance.
Journal: Japanese journal of clinical oncology
Published: May 04, 2023
Last Updated: 09/26/2026